ODI Pharma AB (ODI.ST)

SEK 2.76

(-8.0%)

Eps Summary of ODI Pharma AB

  • ODI Pharma AB's latest annual eps in 2023 was 0.02 SEK , up 105.2% from previous year.
  • ODI Pharma AB's latest quarterly eps in 2023 FY was N/A , up 105.2% from previous quarter.
  • ODI Pharma AB reported an annual eps of -0.45 SEK in 2022, up 6.25% from previous year.
  • ODI Pharma AB reported an annual eps of -0.48 SEK in 2021, down -84.62% from previous year.
  • ODI Pharma AB reported a quarterly eps of 0.09 SEK for 2023 Q3, up 37.14% from previous quarter.
  • ODI Pharma AB reported a quarterly eps of -0.09 SEK for 2023 Q1, up 44.24% from previous quarter.

Annual Eps Chart of ODI Pharma AB (2023 - 2018)

Historical Annual Eps of ODI Pharma AB (2023 - 2018)

Year Eps Eps Growth
2023 0.02 SEK 105.2%
2022 -0.45 SEK 6.25%
2021 -0.48 SEK -84.62%
2020 -0.26 SEK 21.21%
2019 -0.33 SEK -37.5%
2018 -0.24 SEK 0.0%

Peer Eps Comparison of ODI Pharma AB

Name Eps Eps Difference
AcuCort AB -0.16 SEK 114.625%
AlzeCure Pharma AB (publ) -0.60 SEK 103.9%
BioGaia AB (publ) 3.62 SEK 99.354%
Enzymatica AB (publ) -0.28 SEK 108.357%
Enorama Pharma AB (publ) -1.61 SEK 101.453%
Gabather AB (publ) -0.65 SEK 103.6%
Klaria Pharma Holding AB (publ.) -0.36 SEK 106.5%
Moberg Pharma AB (publ) -1.33 SEK 101.759%
Nanexa AB (publ) -1.09 SEK 102.147%
Newbury Pharmaceuticals AB (publ) -0.72 SEK 103.25%
Orexo AB (publ) -3.73 SEK 100.627%
Probi AB (publ) 1.48 SEK 98.419%
Swedencare AB (publ) 0.37 SEK 93.676%
Swedish Orphan Biovitrum AB (publ) 7.47 SEK 99.687%
Toleranzia AB -0.06 SEK 141.786%
Vivesto AB -0.74 SEK 103.162%